Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM). (Q43250016)

From Wikidata
Jump to navigation Jump to search
scientific article published on 2 November 2009
edit
Language Label Description Also known as
English
Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM).
scientific article published on 2 November 2009

    Statements

    title
    Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM) (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    19884643
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884643%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    11 February 2020
    author
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q43250016&oldid=1858029831"